Stephen H. Willard's most recent trade in Longeveron Inc - Ordinary Shares - Class A was a trade of 4,740 Class A Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Longeveron Inc (Class A) | Stephen H. Willard | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. | 01 Apr 2026 | 4,740 | 289,727 | - | 1.1 | 5,309 | Class A Common Stock |
| Longeveron Inc (Class A) | Stephen H. Willard | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 200,000 | 200,000 | - | 0 | Class A Common Stock | |
| Longeveron Inc (Class A) | Stephen H. Willard | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Longeveron Inc (Class A) | Stephen H. Willard | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 200,000 | 294,467 | - | 0 | Class A Common Stock | |
| Longeveron Inc (Class A) | Stephen H. Willard | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 02 Mar 2026 | 105,533 | 94,467 | - | 0.5 | 57,515 | Class A Common Stock |
| NRX Pharma Inc | Stephen H. Willard | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 16 Dec 2022 | 50,000 | 50,000 | - | 1.2 | 58,500 | Common Stock, par value $0.001 per share |